Advil Allergy Sinus
Chlorpheniramine Maleate; Ibuprofen; Pseudoephedrine Hydrochloride
Sourced from the FDA Orange Book
Key dates
Key dates
Approval
FDA approval date of this drug product.
Dec 19, 2002
23 yr 11 mo ago
Today
Patent 7863287 expires
Listed drug product patent expiration.
Feb 28, 2027
in 8 mo
Patent & exclusivity timeline
Pharmaceutical detail
Pharmaceutical detail
Active ingredient
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
Strength
2MG;200MG;30MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 021441
Product number
001
Marketing status
Over-the-counter
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
View full Chlorpheniramine Maleate; Ibuprofen; Pseudoephedrine Hydrochloride familyListed patents
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7863287 | Feb 28, 2027 | in 8 mo | Product |
Advil Allergy Sinus — frequently asked questions
Approval, therapeutic equivalence, patents, and exclusivity for this product, from the FDA Orange Book.
Built directly from the FDA Orange Book data file. This product page links back to the Chlorpheniramine Maleate; Ibuprofen; Pseudoephedrine Hydrochloride active-ingredient family, which is the canonical reference for generics, patents, and exclusivity across all strengths.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsThe list of FDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 & Inspection DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.

